CELESTONE SOLUSPAN (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the CELESTONE SOLUSPAN drug offered from Merck Sharp & Dohme Corp.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Betamethasone Acetate and Betamethasone Sodium Phosphate |
| SUBSTANCE NAME: | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1965-03-15 |
| END MARKETING DATE: | 0000-00-00 |
CELESTONE SOLUSPAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | CELESTONE SOLUSPAN from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3; 3(mg/mL; mg/mL) |
| START MARKETING DATE: | 1965-03-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0085-0566_fba8e08c-0dcb-42ad-b443-53983b429473 |
| PRODUCT NDC: | 0085-0566 |
| APPLICATION NUMBER: | NDA014602 |
Other BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE Pharmaceutical Manufacturers / Labelers:
